1. Home
  2. GH vs CHWY Comparison

GH vs CHWY Comparison

Compare GH & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$110.09

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Chewy Inc.

CHWY

Chewy Inc.

HOLD

Current Price

$32.10

Market Cap

13.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
CHWY
Founded
2011
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
13.5B
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
GH
CHWY
Price
$110.09
$32.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
22
Target Price
$99.48
$45.86
AVG Volume (30 Days)
1.9M
8.0M
Earning Date
02-19-2026
12-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.49
Revenue
$902,569,000.00
$12,584,235,000.00
Revenue This Year
$35.00
$8.66
Revenue Next Year
$26.80
$8.62
P/E Ratio
N/A
$64.64
Revenue Growth
30.38
10.00
52 Week Low
$34.80
$29.83
52 Week High
$113.91
$48.62

Technical Indicators

Market Signals
Indicator
GH
CHWY
Relative Strength Index (RSI) 63.59 43.40
Support Level $106.42 $31.51
Resistance Level $113.91 $33.97
Average True Range (ATR) 3.97 0.93
MACD 0.63 -0.04
Stochastic Oscillator 77.16 39.37

Price Performance

Historical Comparison
GH
CHWY

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About CHWY Chewy Inc.

Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending time developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.

Share on Social Networks: